TEVA PHARMACEUTICAL-SP ADR (TEVA) Institutional Ownership Changes & 13F Activity

TEVA PHARMACEUTICAL-SP ADR (TEVA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Sound Shore Management, Greenlight Capital, ARK Invest, Sequoia Financial Advisors, and Viking Global Investors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2021Miller Value PartnersBuy3,414,36510,554,065$121,794
Q1 2021ARK InvestBuy320,042499,844$5,768
Q4 2020Miller Value PartnersSell-953,9987,139,700$68,898
Q4 2020ARK InvestBuy104,715179,802$1,735
Q4 2020Sequoia Financial AdvisorsSell-3,22810,797$104
Q3 2020Renaissance Technologies LLCSell-2,952,3001,139,163$10,264
Q3 2020Miller Value PartnersBuy243,2268,093,698$72,923
Q3 2020ARK InvestSell-24,90575,087$677
Q2 2020Renaissance Technologies LLCBuy892,4314,091,463$50,448
Q2 2020Miller Value PartnersSell-67,8907,850,472$96,796
Q2 2020ARK InvestBuy43,86999,992$1,233
Q1 2020Miller Value PartnersSell-1,915,7057,918,362$71,107
Q1 2020Renaissance Technologies LLCBuy967,0363,199,032$28,727
Q1 2020Berkshire HathawaySell-460,00042,789,295$384,248
Q1 2020Sequoia Financial AdvisorsBuy14,02514,025$126
Q1 2020ARK InvestBuy9,99456,123$504
Q4 2019Renaissance Technologies LLCSell-4,706,6672,231,996$21,874
Q4 2019Miller Value PartnersBuy1,342,9159,834,067$96,374
Q4 2019ARK InvestSell-10,56946,129$452
Q3 2019Abrams Capital ManagementBuy6,000,00024,046,356$165,439
Q3 2019Renaissance Technologies LLCSell-2,847,4006,938,663$47,738
Q3 2019Miller Value PartnersBuy1,990,9008,491,152$58,419
Q3 2019ARK InvestBuy22,29156,698$390
Q2 2019Renaissance Technologies LLCBuy7,159,9009,786,063$90,325
Q2 2019Miller Value PartnersBuy1,957,7206,500,252$59,997
Q2 2019ARK InvestBuy9,94534,407$318
Q1 2019Renaissance Technologies LLCSell-4,315,8222,626,163$41,178
Q1 2019Miller Value PartnersBuy630,7304,542,532$71,227
Q1 2019Abrams Capital ManagementSell-476,01618,046,356$282,967
Q1 2019ARK InvestBuy85624,462$384

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related TEVA Institutional Insights